Navigation Links
Logical Therapeutics Secures $16.9M Series C Financing Round
Date:5/26/2010

Lead Candidate, LT-NS001, Shows Evidence of Improved GI Safety for Arthritis Patients

WALTHAM, Mass., May 26 /PRNewswire/ -- Logical Therapeutics, Inc., a private, clinical stage biopharmaceutical company, announced today it had closed on a $16.9 million Series C equity financing.  The round was led by existing investor SV Life Sciences, and included Burrill & Company, Novo A/S and Novitas Capital.

Logical Therapeutics is developing a family of new chemical entities using its patented Bio-activated Technology.TM The proprietary platform, which modifies the chemical structure of NSAIDs (non-steroidal anti-inflammatory drugs), is being developed to significantly reduce the gastrointestinal (GI) side effects often associated with NSAIDs.  The Company's lead compound, LT-NS001 (naproxen etemesil), is currently being studied in a Phase 2b/3 study comparing the cumulative rate of gastric ulcers vs. Naprosyn® in osteoarthritis patients after 12 weeks of treatment.  Completion of the study is expected in late 2010.

The Series C financing round is expected to provide sufficient capital to advance the Company's development program through further clinical and non-clinical activities necessary for registration. The Company intends to seek a business partner prior to commercialization.  

About Logical Therapeutics, Inc.

Based in Waltham, MA, Logical Therapeutics, Inc. is a venture-backed, privately held biopharmaceutical company focused on the development of bio-activated prodrugs to treat inflammatory conditions such as osteoarthritis and rheumatoid arthritis.  The Company's Bio-activated Technology
'/>"/>

SOURCE Logical Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Alzheimers Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology
2. Logical Therapeutics Initiates Enrollment in New Gastrointestinal Safety Study in Osteoarthritis Patients
3. Neurobiological Technologies Announces Filing of Certificate of Dissolution and Closing of Stock Transfer Books
4. Tuesday, Dec. 1: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago
5. Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimers Disease
6. Monday, Nov. 30: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago
7. Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago
8. China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits
9. Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share
10. Reportlinker Adds Audiological Devices - Global Market Trends
11. EntreMeds ENMD-2076 Active in Solid and Hematological Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)...  New guidelines released today by the American ... for better outcomes to the hundreds of thousands ... each year. Stryker,s Trevo ® Retriever was ... clinical trials that provided data for this development. ... endovascular therapy with stent retrievers for ischemic stroke ...
(Date:6/29/2015)... 29, 2015  Allergan plc (NYSE: AGN ... second quarter 2015 financial results on Thursday, August ... U.S. financial markets. The Company will host a conference ... Time on Thursday, August 6, 2015 to discuss ... call is U.S./ Canada (877) ...
(Date:6/29/2015)... 2015 Axxess , an industry leader ... software vendor accredited by the American Nursing Credentialing Center ... health agencies select the right revenue cycle management (RCM) ... their business. Research by American Health Information ... expect a decrease in productivity of 54.4 - 69 ...
Breaking Medicine Technology:New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 2Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 3Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2
... CRDC ) today announced that Bernard A. Hausen, M.D., ... present a corporate overview and update at the following conferences: ... November 15, 2011 8:00 a.m. ET New York, NY ... 2011 9:30 a.m. New York, NY To access the ...
... 10, 2011 The Medical Oncology Association of ... recently signed an agreement to work together to ... quality and costs of cancer care in Southern ... clinical, reimbursement and distribution services to help health ...
Cached Medicine Technology:Medical Oncology Association of Southern California, Cardinal Health Specialty Solutions Collaborate With Payors to Improve Quality, Costs, Accessibility of Cancer Care 2Medical Oncology Association of Southern California, Cardinal Health Specialty Solutions Collaborate With Payors to Improve Quality, Costs, Accessibility of Cancer Care 3
(Date:6/29/2015)... ... 2015 , ... Brittenford Systems, a provider of financial management ... across the United States, has announced that it has been named to the ... , Based on company revenue and number of employees, Bob Scott’s Top 100 ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... new approach to build nearly complete genomes by combining high-throughput DNA sequencing with ... critically important for their association with human disease, but previously difficult to detect. ...
(Date:6/29/2015)... San Fernando Valley, CA (PRWEB) , ... June 29, 2015 , ... ... offering non-invasive treatments designed to lift and tighten sagging skin. Ulthera is a special ... or surgery. Instead, it uses ultrasound technology to gently stimulate collagen production. Ulthera is ...
(Date:6/29/2015)... ... 2015 , ... The Food Safety and Technology Research Centre ... Polytechnic University (PolyU) has developed a new method for rapid authentication of edible ... long-term issue in food safety, and becomes particularly important with the emergence and ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... serving the Twin Cities area, provides money-saving tactics during a season of increased ... Cities’ residents, addressing water conservation and other economical practices. , According to the ...
Breaking Medicine News(10 mins):Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 2Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 3Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2Health News:Save Energy: MSP Plumbing, Heating & Air Endorses Efficiency 2Health News:Save Energy: MSP Plumbing, Heating & Air Endorses Efficiency 3
... low in carbohydrates may help stunt the growth of prostate ... Center researchers. The study, in mice, suggests that a reduction ... tumor growth. , This study showed that cutting carbohydrates may ... M.D., a urologist at Duke University Medical Center and lead ...
... NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ), the ... hospitals throughout the United States,today announced that it ... Conference, November 28, 2007, at 2:30 p.m. EST ... Mayleben, President and Chief Operating,Officer, and Glenn Cole, ...
... lopinavir/ritonavir,Tablet Available in More Than 150 Countries to Support ... More Than 2 Million Children Living ... Abbott today,announced that it has received U.S. Food ... formulation of its leading HIV,protease inhibitor, Kaletra(R) (lopinavir/ritonavir), which ...
... staff safety and minimizing waste ... ... of a world-class,sales and service organization and a manufacturing organization ... transform,the way cancer fighting drugs are prepared and administered. The,combination ...
... 205% Year-Over-Year, SHANGHAI, China, Nov. 12 /Xinhua-PRNewswire/ ... ("WuXi PharmaTech" or "the Company"), the leading,China-based pharmaceutical ... its selected unaudited financial,results for the third quarter ... Highlights:, -- Total net revenues increased ...
... Surgical Care Affiliates,(SCA) has signed a lease with ... expects to move into the new space during the ... created by HealthSouth,s sale,of its surgery division to TPG ... in its network of more than 130 outpatient surgery ...
Cached Medicine News:Health News:A low-carb diet may stunt prostate tumor growth 2Health News:NightHawk Radiology Holdings, Inc. to Speak at Annual Piper Jaffray Healthcare Conference on November 28, 2007 2Health News:Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients 2Health News:Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients 3Health News:Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients 4Health News:Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients 5Health News:Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients 6Health News:Primus Innovations and Health Robotics Launch Strategic Partnership to Accelerate Transformation in Chemotherapy Compounding 2Health News:WuXi PharmaTech Announces Third Quarter 2007 Results 2Health News:WuXi PharmaTech Announces Third Quarter 2007 Results 3Health News:WuXi PharmaTech Announces Third Quarter 2007 Results 4Health News:WuXi PharmaTech Announces Third Quarter 2007 Results 5Health News:WuXi PharmaTech Announces Third Quarter 2007 Results 6Health News:WuXi PharmaTech Announces Third Quarter 2007 Results 7Health News:WuXi PharmaTech Announces Third Quarter 2007 Results 8Health News:WuXi PharmaTech Announces Third Quarter 2007 Results 9Health News:WuXi PharmaTech Announces Third Quarter 2007 Results 10Health News:WuXi PharmaTech Announces Third Quarter 2007 Results 11Health News:Surgical Care Affiliates Announces New Home Office Location 2
ZapICD is a reference to the complete set of ICD codes....
... The MD Coder is simply ... it is a handheld solution ... tracking for both individual physicians ... Coder v6.0 now comes in ...
In addition to the patient data OB-on-Call contains a comprehensive Medications list displaying related drugs by brand name, generic title, and usage description notes....
... Derived from the ... Information database, this continually ... guidelines on thousands of ... generic drugs and now ...
Medicine Products: